INS and metabolic dysfunction-associated steatotic liver disease: Pathways including ABC transporters, pyrimidine metabolism, purine metabolism, glucagon signaling, insulin signaling, glycolysis/gluconeogenesis and NAFLD were enriched by analysis of differential metabolites.